ES480624A1 - A Purified Cancer Associated Protein - Google Patents

A Purified Cancer Associated Protein

Info

Publication number
ES480624A1
ES480624A1 ES480624A ES480624A ES480624A1 ES 480624 A1 ES480624 A1 ES 480624A1 ES 480624 A ES480624 A ES 480624A ES 480624 A ES480624 A ES 480624A ES 480624 A1 ES480624 A1 ES 480624A1
Authority
ES
Spain
Prior art keywords
cadet
iac
associated protein
cancer associated
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES480624A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALFERD BENZON AS
Original Assignee
ALFERD BENZON AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALFERD BENZON AS filed Critical ALFERD BENZON AS
Publication of ES480624A1 publication Critical patent/ES480624A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A purified protein (CaDet) which in SDS Page gradient shows a molecular weight of about 25,000 Daltons has been eluted from antibody affinity columns with immobilized antibodies specifically directed against the protein C1 IAC described in U.S. Patent No. 4,132,769, by elution with a detergent. CaDet reacts with anti C1 IAC in immunoprecipitation tests and, when used for immunization, CaDet gives increased titers of anti C1 IAC.
ES480624A 1978-05-17 1979-05-16 A Purified Cancer Associated Protein Expired ES480624A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK216378 1978-05-17

Publications (1)

Publication Number Publication Date
ES480624A1 true ES480624A1 (en) 1980-08-16

Family

ID=8110498

Family Applications (1)

Application Number Title Priority Date Filing Date
ES480624A Expired ES480624A1 (en) 1978-05-17 1979-05-16 A Purified Cancer Associated Protein

Country Status (15)

Country Link
JP (1) JPS5516291A (en)
AU (1) AU521404B2 (en)
BE (1) BE876301A (en)
DE (1) DE2919833A1 (en)
ES (1) ES480624A1 (en)
FI (1) FI791551A7 (en)
FR (1) FR2426055A1 (en)
GB (1) GB2021593A (en)
IT (1) IT7968046A0 (en)
LU (1) LU81273A1 (en)
NL (1) NL7903854A (en)
NO (1) NO791643L (en)
NZ (1) NZ190470A (en)
PT (1) PT69617A (en)
SE (1) SE7904276L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0087898A1 (en) * 1982-02-22 1983-09-07 Cancer Research Campaign Technology Limited Antibodies and antigens useful in the diagnosis and treatment of cancer
ZW7583A1 (en) * 1982-04-07 1983-06-29 Baylor College Medicine Products and methods for treatment of cancer

Also Published As

Publication number Publication date
NL7903854A (en) 1979-11-20
DE2919833A1 (en) 1979-11-29
GB2021593A (en) 1979-12-05
LU81273A1 (en) 1979-09-10
NO791643L (en) 1979-11-20
JPS5516291A (en) 1980-02-04
SE7904276L (en) 1979-11-18
FI791551A7 (en) 1981-01-01
IT7968046A0 (en) 1979-05-17
BE876301A (en) 1979-11-16
FR2426055A1 (en) 1979-12-14
NZ190470A (en) 1982-06-29
AU521404B2 (en) 1982-04-01
PT69617A (en) 1979-06-01
AU4717279A (en) 1979-11-22

Similar Documents

Publication Publication Date Title
ES2106195T3 (en) IGG AGLYCOSILATED ANTIBODY ANTI CD3.
EP0458841A4 (en) Method for the use and synthesis of peptides
EP0930366A3 (en) Binding domains in delta proteins
AU3777989A (en) Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
GB2128630A (en) Method of affinity purification employing monoclonal antibodies
HUT41836A (en) Process for preparing monoclonal antibodies cross-reactive and cross-protecting against p. aeruginosa serotypes
EP0517853A4 (en) Method for detection of -i(borrelia burgdorferi), purified antigen thereof and antibody capable of binding therewith
AU1378395A (en) Metal chelators
IL92037A0 (en) Novel family of high affinity,modified antibodies for cancer treatment
CA2080548A1 (en) Monoclonal antibodies to hepatitis c virus
ES480624A1 (en) A Purified Cancer Associated Protein
YU46858B (en) PROCEDURE FOR OBTAINING IMMUNOGLOBULIN CONJUGATES
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies
IE860758L (en) Anaplasma marginale subunit antigen for vaccination and¹diagnosis
WO1994021812A3 (en) Hepatitis b escape mutant specific binding molecules
Hudson et al. The use of column-bound B lymphocytes for absorption of antisera to T lymphocyte antigens
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
AU1626492A (en) Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
AU7955687A (en) Method for purification of antibodies
ZA868673B (en) Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes
EP0313538A3 (en) Monoclonal antibody, a process for its preparation and the use thereof
FI925081A7 (en) Method for preparing an antigen-specific, high affinity monoclonal antibody
AU653182B2 (en) Process for selective removal of salivary alpha-amylase and assay for pancreatic alpha-amylase
MY102245A (en) Purification of antibodies
Fishwild ON THE IMMUNOCHEMICAL AND BIOCHEMICAL DEFINITION OF A NUCLEAR ANTIGEN SCL-70 REACTIVE WITH AUTOANTIBODIES IN PROGRESSIVE SYSTEMATIC SCLEROSIS.